Compare Arm Holdings plc (ARM) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arm Holdings plc vs Neurocrine Biosciences Inc — how do they compare? Arm Holdings plc trades at $274.3 (market cap $287.22B), while Neurocrine Biosciences Inc trades at $152.18 (market cap $16.46B). The key difference: Arm Holdings plc is far larger — about 17.4× Neurocrine Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ARM | NBIX | |
|---|---|---|
Market Cap | $287.22B | $16.46B |
Sector | Technology | Health |
52-Week High | $439.46 | $185.50 |
52-Week Low | $104.55 | $123.10 |
Enterprise Value | $283.79B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arm Holdings plc
Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.
Read more on ARM →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
